Lauren Rastedder

Learn More
The use of autoantibodies for the early detection of breast cancer has generated much interest as antibodies can be readily assayed in serum when antigen levels are low. Ideally, diagnostic autoantibodies would be identified in individuals who harbored pre-invasive disease/high risk lesions leading to malignancy. Prospectively collected human serum samples(More)
Breast cancer is immunogenic and proteins expressed in breast cancer stimulate both an antibody and a T-cell immune response. Cancer related proteins that are aberrant enough to trigger early immune recognition might be ideal targets for a vaccine aimed at preventing the development of breast cancer. Antigen discovery has focused on the identification of(More)
  • 1